Literature DB >> 1739949

Cystatins and stefins in ascites fluid from ovarian carcinoma.

T T Lah1, M Kokalj-Kunovar, L Kastelic, J Babnik, A Stolfa, S Rainer, V Turk.   

Abstract

Cysteine proteinase inhibitors (CpI) of all three families were found in ascites fluid from patients with ovarian carcinoma. CPIs were isolated by affinity chromatography on carboxymethylated papain Sepharose, followed by gel filtration, anti-stefin-Sepharose and ion exchange chromatography. The highest apparent inhibition against cathepsin B (Cat B) was found in the low molecular mass (LMM) CPI fraction. Immunochemical analysis of this fraction revealed the presence of cystatin C and both stefins A and B while the high molecular mass (HMM) CPI fraction contained kininogens. We demonstrated that CPIs were not completely associated with cysteine proteinases (CPs): about 20% of HMM CPIs and 50% of LMM CPIs were free in native ascites fluid. Affinity chromatography on anti-Cat B-Sepharose revealed that the major LMM CPI, associated with Cat B in native ascites fluid, was the full length form of cystatin C, pI 9.3, and not its truncated form, pI 7.85. The latter was isolated and found to inhibit Cat B in vitro with apparent Ki 0.18 +/- 0.2 nM. Stefin A was isolated from alkaline activated ascites fluid in its two isoforms, pI 4.6 and 4.9. In native ascites, the pI 4.9 isoform was mostly associated with Cat B. Ki for Cat B was 3.55 +/- 1.7 nM, not significantly different from the Ki values measured for stefin A, isolated from other human tissues and biological fluids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739949     DOI: 10.1016/0304-3835(92)90295-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Authors:  H H Heidtmann; U Salge; M Abrahamson; M Bencina; L Kastelic; N Kopitar-Jerala; V Turk; T T Lah
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

2.  Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer.

Authors:  Suzie E Ahn; Jin Won Choi; Deivendran Rengaraj; Hee Won Seo; Whasun Lim; Jae Yong Han; Gwonhwa Song
Journal:  Reprod Biol Endocrinol       Date:  2010-08-21       Impact factor: 5.211

3.  Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.

Authors:  Xingxing Wang; Lu Gui; Youyuan Zhang; Jihong Zhang; Jimin Shi; Guoxiong Xu
Journal:  Int J Oncol       Date:  2014-01-21       Impact factor: 5.650

4.  Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.

Authors:  Urška Verbovšek; Helena Motaln; Ana Rotter; Nadia A Atai; Kristina Gruden; Cornelis J F Van Noorden; Tamara T Lah
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

5.  Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors.

Authors:  Eva Kolwijck; Leon F A G Massuger; Chris M G Thomas; Paul N Span; Marta Krasovec; Janko Kos; Fred C G J Sweep
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-14       Impact factor: 4.553

6.  Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer.

Authors:  Elena A Gashenko; Valentina A Lebedeva; Ivan V Brak; Elena A Tsykalenko; Galina V Vinokurova; Tatyana A Korolenko
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.